• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测癫痫患者血浆卡马西平浓度范围。

Predicting the range of plasma carbamazepine concentrations in patients with epilepsy.

作者信息

Racine-Poon A, Dubois J P

机构信息

Mathematical Applications, CIBA-GEIGY AG, Switzerland.

出版信息

Stat Med. 1989 Nov;8(11):1327-37. doi: 10.1002/sim.4780081105.

DOI:10.1002/sim.4780081105
PMID:2609045
Abstract

A statistical model is proposed for predicting the range of plasma carbamazepine concentrations after administration of a controlled-release formulation at steady state. The model is based on previous clinical studies in patients with epilepsy. The predicted range may be used to monitor and adjust treatment in a patient.

摘要

提出了一种统计模型,用于预测在稳态下给予控释制剂后血浆卡马西平浓度的范围。该模型基于先前对癫痫患者的临床研究。预测范围可用于监测和调整患者的治疗。

相似文献

1
Predicting the range of plasma carbamazepine concentrations in patients with epilepsy.预测癫痫患者血浆卡马西平浓度范围。
Stat Med. 1989 Nov;8(11):1327-37. doi: 10.1002/sim.4780081105.
2
Pharmacokinetic evaluation of twice-daily extended-release carbamazepine (CBZ) and four-times-daily immediate-release CBZ in patients with epilepsy.癫痫患者中每日两次缓释卡马西平(CBZ)与每日四次速释卡马西平的药代动力学评估。
Epilepsia. 1998 Mar;39(3):274-9. doi: 10.1111/j.1528-1157.1998.tb01372.x.
3
Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.基于癫痫患儿稀疏治疗监测数据建立卡马西平群体药代动力学模型。
Clin Ther. 2005 May;27(5):618-26. doi: 10.1016/j.clinthera.2005.05.001.
4
Slow release carbamazepine in treatment of poorly controlled seizures.缓释卡马西平治疗癫痫控制不佳的情况。
Arch Dis Child. 1990 Sep;65(9):930-5. doi: 10.1136/adc.65.9.930.
5
Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.埃及癫痫患者稳态卡马西平的群体药代动力学。
J Clin Pharm Ther. 2012 Jun;37(3):352-5. doi: 10.1111/j.1365-2710.2011.01296.x. Epub 2011 Aug 23.
6
Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex.癫痫患者口服和静脉内稳定标记后卡马西平的药代动力学稳态:种族和性别的影响。
Clin Pharmacol Ther. 2012 Mar;91(3):483-8. doi: 10.1038/clpt.2011.251. Epub 2012 Jan 25.
7
Replacing carbamazepine slow-release tablets with carbamazepine suppositories: a pharmacokinetic and clinical study in children with epilepsy.用卡马西平栓剂替代卡马西平缓释片:一项针对癫痫儿童的药代动力学和临床研究。
J Child Neurol. 1995 Mar;10(2):114-7. doi: 10.1177/088307389501000209.
8
[Role of the pharmacokinetic parameters of carbamazepine in optimizing epilepsy treatment].[卡马西平药代动力学参数在优化癫痫治疗中的作用]
Zh Nevropatol Psikhiatr Im S S Korsakova. 1987;87(9):1327-9.
9
A comparative evaluation of pharmacokinetics of conventional and slow-release carbamazepine formulation in newly treated patients of epilepsy: a random evaluation.癫痫新治疗患者中传统剂型与缓释型卡马西平制剂药代动力学的比较评价:一项随机评估。
J Assoc Physicians India. 1998 Feb;46(2):185-8.
10
[Concentration of carbamazepine in plasma during long term anti-epilepsy treatment].长期抗癫痫治疗期间血浆中卡马西平的浓度
Bibl Psychiatr. 1975(151):28-31.